Showing Latest Articles
Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention
European Heart Journal, 03/10/2010
Rassen JA et al. – In this non–randomized study of routine care, the authors observed a reduction in blood transfusions and in short–term mortality for patients treated with bivalirudin compared with heparin plus GPI. The mortality benefit was more pronounced in this study than in randomized trials.
